Aarti Drugs moves up on the BSE

07 Jul 2023 Evaluate

Aarti Drugs is currently trading at Rs. 473.55, up by 3.25 points or 0.69% from its previous closing of Rs. 470.30 on the BSE.

The scrip opened at Rs. 465.00 and has touched a high and low of Rs. 476.00 and Rs. 464.45 respectively. So far 6317 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 511.65 on 06-Oct-2022 and a 52 week low of Rs. 310.80 on 20-Mar-2023.

Last one week high and low of the scrip stood at Rs. 476.00 and Rs. 456.85 respectively. The current market cap of the company is Rs. 4403.59 crore.

The promoters holding in the company stood at 59.58%, while Institutions and Non-Institutions held 6.03% and 34.39% respectively.

Aarti Drugs has won Pharmexcil Outstanding Exports Award 2021-2022. The company has received Export Performance Award – API & Intermediaries Gold Star for the year 2021-22 on July 5, 2023, in recognition of commendable contribution to the pharmaceutical export of India.

The awards were presented during the ‘iPHEX 9th edition of Indian Pharmaceutical Exhibition’ organized by the Pharmaceuticals Export Promotion Council (Pharmexcil) and sponsored by Department of Commerce & Industry, Government of India where all the major India Pharmaceutical companies had participated.

The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

374.05 -1.15 (-0.31%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×